CNS and oncology appear prime targets for Proteus and Otsuka's 'digital medicines'
This article was originally published in Scrip
Executive Summary
In another sign of the blurring boundaries between therapeutics and medical technology, Otsuka Pharmaceutical has put down its marker in the area of drug compliance management, linking up with Proteus Digital Health for the joint development and commercialisation of "digital medicines".